[Treatment of cardiac insufficiency in the acute stage of cardiac infarct].
The studies on Strophantin effect upon the hemodynamics in the acute stage of cardiac infarction has revealed that it elevates the pressure in pulmonary artery and reduces the cardiac output, in certain cases deteriorating the patient's state. Furanthril and Droperidol reduce the cardiac output but at the same time diminish the pressure in the pulmonary artery and reduce the pulmonary resistance, thus having a favourable effect on the patient's state. Proceeding from the results obtained, a treatment scheme, including Furanthril, Droperidol and Strophantin, is recommended for the cardiac insufficiency treatment in the acute stage of cardiac infarction depending on the disease onset and the degree of cardiac insufficiency manifested.
D000208:Acute Disease; D001794:Blood Pressure / Q000187:drug effects; D004329:Droperidol / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013328:Strophanthins / Q000627:therapeutic use; D013997:Time Factors
D013328:Strophanthins; D005665:Furosemide; D004329:Droperidol
Lechenie na surdechnata nedostatuchnost v ostriia stadiĭ na surdechniia infarkt.